STING, havinggenerated significant interest within the medical research community, iscurrently considered one of the fastest growing areas of cancer immunotherapyand is being pursued by several large pharmaceutical companies
Roots Analysis is pleased toannounce the publication of its recent study, titled, “STING Pathway TargetingTherapeutics and Technologies, 2020-2030.”
The report features an extensive study of the current marketlandscape and future potential of these therapeutics and affiliatedtechnologies, over the next decade. This study focuses specifically on smallmolecule STING modulators. The report features an in-depth analysis, highlightingthe diverse capabilities of stakeholders engaged in this domain. In addition toother elements, the study includes:
§ A detailed assessmentof the current market landscape of therapeutics targeting STING Pathway.
§ A detailed assessmentof the current market landscape of various technology platforms that are beingactively used for the development of STING modulators.
§ Detailed profiles ofdevelopers of therapeutics targeting STING pathway (shortlisted on thebasis of phase of development of pipeline products).
§ An in-depth analysisof more than 280 grants that have been awarded to research institutes engagedin STING pathway targeting therapeutics-related projects.
§ An analysis of theinitiatives of big pharma players engaged in this domain.
§ An analysis of thestart-ups / small players (established in the last ten years, less than 50employees) engaged in the development of STING pathway targetingtherapeutics.
§ A detailedpublication analysis of more than 300 peer-reviewed, scientific articles thathave been published during the period 2019 - Q1 2020.
§ An analysis of thepartnerships that have been established in this domain, in the recent past.
§ An analysis of theinvestments made in this domain.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Types of Payment
§ Upfront Payments
§ Milestone Payments
§ Type of STINGModulator
§ Agonist
§ Antagonist
§ Key TherapeuticArea(s)
§ Oncological Disorders
§ InflammatoryDisorders
§ Infectious Diseases
§ Others
§ Route ofAdministration
§ Intratumoral
§ Intravenous
§ Oral
§ Subcutaneous
§ Others
§ Type of Molecule
§ Non-nucleotide
§ Cyclic Dinucleotide
§ Live Biotherapeutics
§ Oncolytic Peptides
§ Synthetic Peptides
§ Others
§ Key GeographicalRegions
§ North America
§ Europe
§ Asia-Pacific
Keycompanies covered in the report
§ Aduro Biotech
§ Bristol Myers Squibb
§ Eisai
§ GlaxoSmithKline
§ ImmuneSensor Therapeutics
§ Merck
§ Noxopharm
§ Spring Bank Pharmaceuticals
§ Synlogic
Formore information please click on the following link:
Other RecentOfferings
1. Nuclear Medicine andRadiopharmaceuticals Manufacturing Market, 2020-2030
2. Global Psychedelic TherapeuticsMarket by Type ofPsychedelic Substance (Ketamine, Psilocybin, MDMA and Others), by Origin(Natural and Synthetic), by Type of Therapy (Monotherapy, Combination andOthers), by Route of Administration (Oral, Intravenous, Intranasal and Others)and by Key Geographies (North America, Europe and Asia- Pacific and rest of theworld): Industry Trends and Global Forecasts, 2020-2030
3. Endocannabinoid System TargetedTherapeutics Market,2020-2030
About Roots Analysis
Roots Analysis is one of the fastestgrowing market research companies, sharing fresh and independent perspectivesin the bio-pharmaceutical industry. The in-depth research, analysis andinsights are driven by an experienced leadership team which has gained manyyears of significant experience in this sector. If you’d like help with yourgrowing business needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter- https://twitter.com/RootsAnalysis
